GMTX: Gemini Therapeutics, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Gemini Therapeutics, Inc.

NASDAQ:GMTX

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$22.00
Loss Chance
58.4%
0.85JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
The Central and Eastern Europe Fund
NYSE:CEE
4.41
$8.07
53.66%
United States Commodity Index Funds Trust - United States Copper Index Fund
NYSE:CPER
3.32
$20.84
38.04%
Invesco DB Commodity Index Tracking Fund
NYSE:DBC
2.67
$25.19
16.43%
Guggenheim Strategic Opportunities Fund
NYSE:GOF
4.18
$17.02
14.82%
iShares S&P GSCI Commodity-Indexed Trust
NYSE:GSG
2.61
$21.72
28.20%
Jitta Factors
Growth Opportunity (10)
Recent Business Performance (33)
Financial Strength (33)
Return to Shareholders (0)
Competitive Advantage (6)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
0.85
100.00%
2.08
347.10%
2.08
347.10%
4.41
53.66%
3.32
38.04%
2.67
16.43%
COMPANY DESCRIPTION
As of December 29, 2022, Gemini Therapeutics, Inc. was acquired by Disc Medicine, Inc., in a reverse merger transaction. Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 for treatment of systemic diseases. Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
www.geminitherapeutics.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.